Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

Clariant. (1/25/18). "Press Release: SABIC Acquires 24.99% Stake in Clariant. SABIC Acquires Stakes Previously Held by 40 North and Corvex Management". Muttenz.

Organisations Organisation Clariant Ltd. (CH)
  Group Clariant (Group)
  Organisation 2 SABIC (Saudi Basic Industries Corporation)
  Group SABIC (Saudi Basic Industries Corporation) (Group)
Products Product chemicals (excl. pharmaceuticals)
  Product 2 petrochemicals
Index term Index term Clariant–SABIC: investment, 201801 acquisition 24.99% shareholding by SABIC via acquisition of shares previously held by White Tale + 40 North

> Clariant acknowledges investment by chemical industry peer and partner SABIC

> Clariant and SABIC to engage in discussions

Clariant, a world leader in specialty chemicals, today acknowledges the investment by chemical industry peer and partner SABIC, which has acquired a 24.99% stake in Clariant. The acquisition of these stakes, which were previously held by White Tale and 40 North, makes SABIC the largest Clariant shareholder.

As is customary in the industry, Clariant was informed of SABIC’s intention to acquire the shares prior to the transaction. SABIC is one of the major global chemical companies, with a significant specialty chemicals business and a partner of Clariant in the Catalyst joint venture Scientific Design.

Clariant intends to engage with SABIC over the coming weeks in order to discuss the new situation and explore possible ways to create value. Clariant will also continue the existing dialogue with all its other shareholders.


Phone +41 61 469 63 63

Phone +41 61 469 63 63

Phone +41 61 469 63 63


Phone +41 61 469 63 73

Phone +41 61 469 63 73

Follow us on Twitter, Facebook, Google Plus, LinkedIn.

Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On 31 December 2016 the company employed a total workforce of 17 442. In the financial year 2016, Clariant recorded sales of CHF 5.847 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on five pillars: focus on innovation through R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability.

Record changed: 2018-02-01


Picture [LSA] – The Business Web Portal 650x89px

More documents for Clariant (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top